TerSera® Receives National Recognition as a 2025 USA TODAY Top Workplace

TerSera Therapeutics is proud to announce its recognition as a 2025 Top Workplace by USA TODAY, a prestigious award that highlights the company's achievements in cultivating an exceptional workplace culture. This follows TerSera’s recognition as a 2024 Healthcare Industry Top Workplace, a 2024 Chicago Tribune Top Workplace, and Culture Excellence Awards across a number of different categories including Leadership, Purpose & Values, Employee Appreciation and Well-Being, Professional Development, and Compensation & Benefits.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520564079/en/

USA TODAY -- Top Work Places 2025 in the United States

“We have built our patient and people-centered organization by trusting and empowering our team members and valuing each individual’s unique contributions,” said Edward Donovan, Chief Executive Officer of TerSera. “We are honored to be recognized as one of the top workplaces in the country, especially given the award is based on the sentiment of our employees. Thank you to our team of one-and-only professionals who make TerSera a great place to work.”

The Top Workplaces USA designation is based exclusively on employee feedback, gathered through an independent survey conducted by Energage, a leading HR technology and research firm. More than 42,000 organizations were invited to participate in the Top Workplaces survey, which recognizes organizations with 150 or more employees that have established best-in-class workplace cultures. Employee survey results were evaluated using research-backed metrics that measure workplace culture, leadership, and employee experience.

About TerSera Therapeutics

TerSera Therapeutics is a biopharmaceutical company with a focus in oncology and non-opioid pain management. Founded in 2016, TerSera is building new cornerstones of care through its portfolio of unique therapeutics, amplifying their ability to deliver meaningful outcomes for patients. For additional information, please visit TerSera.com and follow us on LinkedIn.

©2025 TerSera Therapeutics LLC. All rights reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250520564079/en/